verified SJR 0,123 · Q4 • database Scopus / SJR indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q4 — Molecular Biology lock Subscription

Current Pharmacogenomics and Personalized Medicine

Current Pharmacogenomics and Personalized Medicine is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 23. It has an SJR impact factor of 0,123 and it has a best quartile of Q4. It has an SJR impact factor of 0,123.

ISSN: 1875-6921

Publisher: Bentham Science Publishers

Category: Molecular Biology

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,123 Q4

H-index 23

Acceptance rate pie_chart

41%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,123

H-index

Docs (year)

Docs 3y

Total refs

946

Cites 3y

Citable 3y

Cites/Doc 2y

0.25

Ref/Doc

59.13

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Do Estrogen Receptor β Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?

Validation of Traditional Medicinal Practices through Modern Scientific Tools and Techniques

Editorials [Conference Scene in Global Personalized Medicine: CINP Thematic Meeting on Pharmacogenomics and Personalised Medicine in Psychiatry, Jerusalem, Israel (April 21-23, 2013)]

Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)]

Editorial [Revisiting the Paris Declaration: Pharmacogenomics and Personalized Medicine as Accelerators for Development Aid and Effectiveness]

Editorial [Rethinking Pharmacogenomics in an Ecosystem: Drug-microbiome Interactions, Pharmacomicrobiomics, and Personalized Medicine for the Human Supraorganism]

Editorial [Personalized Nutrition, Genomics and the Right to Food: No Person is an Island]

Editorial (Personalised Medicine: Lessons from Birth Defects and Single Gene Disorders)

Editorial (Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value)

Editorial (Moving Beyond Our Mutual Ignorance. Or, How would Engaging the Public Benefit the Personalized Medicine Community?)

Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine)

Eating Disorder Symptoms and CYP2D6 Variation in Cuban Healthy Females: A Report from the Ibero-American Network of Pharmacogenetics

SHOW MORE ARTICLES

Drug Abuse Treatment through Gene Manipulation Using Nanomedicine

"Self-Antigenic Universe" and Tuberculosis Vaccine Development

Differences in MDR1 (C3435T), CYP2D6, and CYP1A2 Genotype Frequencies between Patients with Treatment Failure to Antipsychotics and Healthy Russian Population

Determinants of Treatment Outcomes for Hepatitis C Infection and the Path to Personalized Medicine

Dermatology and Global Health Meet Pharmacogenomics: Cutaneous Leishmaniasis

Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors

Computational Simulations of the Immune System for Personalized Medicine: State of the Art and Challenges

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga

Capacity Building in Genomics Medicine and Molecular Diagnostics: The Case of Sri Lanka

Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers

Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives

A New Risk Chart of Acute Myocardial Infarction in Men by an Innovative Algorithm: A Pilot Study

FAQs

Current Pharmacogenomics and Personalized Medicine has an SJR of 0,123 (best quartile Q4) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Pharmacogenomics and Personalized Medicine is 41%.

Current Pharmacogenomics and Personalized Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Pharmacogenomics and Personalized Medicine?

What is the APC / publication cost?

What is the acceptance rate?